Pathophysiology of type 2 diabetes and the impact of altered metabolic interorgan crosstalk.

Sanches, Jose Marcos; Zhao, Li Na; Salehi, Albert; Wollheim, Claes B; Kaldis, Philipp

Sanches, Jose Marcos; Zhao, Li Na; Salehi, Albert; Wollheim, Claes B; Kaldis, Philipp.

Afiliação

Sanches JM; Department of Clinical Sciences, Lund University, Malmö, Sweden.
Zhao LN; Department of Clinical Sciences, Lund University, Malmö, Sweden.
Salehi A; Department of Clinical Sciences, Lund University, Malmö, Sweden.
Wollheim CB; Department of Clinical Sciences, Lund University, Malmö, Sweden.
Kaldis P; Department of Cell Physiology and Metabolism, University of Geneva, Geneva, Switzerland.

FEBS J ; 290(3): 620-648, 2023 02.

Article em En | MEDLINE | ID: mdl-34847289

Assuntos

Diabetes Mellitus Tipo 2; Resistência à Insulina; Humanos; Diabetes Mellitus Tipo 2/tratamento farmacológico; Resistência à Insulina/genética; Glicemia/metabolismo; Qualidade de Vida; Aminoácidos/metabolismo

Palavras-chave

diabetes; free fatty acids; inflammation; interorgan crosstalk; liver; metabolites; metabolomics; organokines; type 2 diabetes

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Resistência à Insulina / Diabetes Mellitus Tipo 2 Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google